Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 2/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | MAP4K1 | Q92918 | 2/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | PI4KA | P42356 | 1/20 | 0.30 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.30 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.30 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.30 |
| ▸ | MLYCD | O95822 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1951450 | 0.71 | ALDH1A1 (0.42) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| Methylamine SCHEMBL6091448 | 0.70 | PKM (0.57) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL6092162 | 0.69 | APOBEC3A (0.36) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL12724350 | 0.69 | ALDH1A1 (0.44) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL12724434 | 0.69 | ALDH1A1 (0.41) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL21440780 | 0.67 | MEN1 (0.35) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL12499907 | 0.67 | MAPT (0.41) | TBXAS1KMT2ASMN1; SMN2 | |
| SCHEMBL7987138 | 0.66 | PKM (0.44) | PKMGAATSHRBRD4KMT2A | |
| SCHEMBL11725392 | 0.66 | PKM (0.44) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL28558147 | 0.64 | ALDH1A1 (0.44) | HPGDGAAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060135587-A1 | Method and compounds for promoting healing and reducing inflammation | BIODIEM, LTD. (AU) | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135587-A1 | Method and compounds for promoting healing and reducing inflammation | IL1B, MIF, ALKBH5 | APOBEC3A 3574/4885APOBEC3G 3236/4885HPGD 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.